We studied the relationships between blepharospasm (BSP) and menopause/menarche in female patients with primary BSP (n = 83) and age-matched healthy (n = 83) and disease controls (n = 83). BSP patients and matched controls had comparable age at menopause, and there was no correlation between age at menopause and age at BSP onset. Thus, menopause probably exerts no significant influence on the age-dependent development of BSP. BSP cases tended to have a later menarche than either group of controls. The association was independent of age, disease duration and education level. Because the higher the age at menarche, the higher the age at BSP onset, later menarche was unlikely to be a risk factor for BSP. Rather, the two conditions may share pathophysiologic mechanisms, for example minor abnormality of neurotransmitter systems controlling both the motor system and the maturation of the hypothalamic-pituitary-gonadal axis responsible for the onset of puberty.

Keywords:
Blepharospasm, Menarche, Menopause
1.
Fahn S, Bressman SB, Marsden CD: Classification of dystonia. Adv Neurol 1998;78:1–10.
2.
Duffey PO, Butler AG, Hawthorne MR, Barnes MP: The epidemiology of the primary dystonias in the north of England. Adv Neurol 1998;78:121–125.
3.
Defazio G, Livrea P, De Salvia R, Manobianca G, Coviello V, Anaclerio D, Guerra V, Martino D, Valluzzi F, Liguori R, Logroscino G: Prevalence of primary blepharospasm in a community of Puglia region, Southern Italy. Neurology 2001;56:1579–1581.
4.
Duane DD: Spasmodic torticollis: Clinical and biologic features and their implications for focal dystonia. Adv Neurol 1988;50:473–492.
5.
Kompoliti K: Estrogen and movement disorders. Clin Neuropharmacol 1999;22:318–326.
6.
Koller WC, Barr AL, Biary N: Estrogen treatment of dyskinetic disorders. Neurology 1982;32:547–549.
7.
Thompson KN, Kulkarni J, Sergejew AA: Extrapyramidal symptoms and oestrogen. Acta Psychiatr Scand 2000;101:130–134.
8.
Loscher W, Blanke T, Richter A, Hoppen HO: Gonadal sex hormones and dystonia: Experimental studies in genetically dystonic hamsters. Mov Disord 1995;10:92–102.
9.
McKinlay SM: The normal menopause transition: An overview. Maturitas 1996;23:137–145.
10.
Veronesi FM, Gueresi P: Trend in menarcheal age and socioeconomic influence in Bologna (northern Italy). Ann Human Biol 1994;21:187–196.
11.
Meschia M, Pansini F, Modena AB, de Aloysio D, Gambacciani M, Parazzini F, Campagnoli C, Maiocchi G, Peruzzi E: Determinants of age at menopause in Italy: Results from a large cross-sectional study. ICARUS Study Group. Italian Climacteric Research Group Study. Maturitas 2000;34:119–125.
12.
Defazio G, Berardelli A, Abbruzzese G, Coviello V, Carella F, De Berardinis MT, Galardi G, Girlanda P, Maurri S, Mucchiut M, Albanese A, Basciani M, Bertolasi L, Liguori R, Tambasco N, Santoro L, Assennato G, Livrea P: Risk factors for spread of primary adult onset blepharospasm: A multicentre investigation of the Italian Movement Disorders Study Group. J Neurol Neurosurg Psychiatry 1999;67:613–619.
13.
Campfield LA, Smith FJ, Guisez Y, Devos R, Burn P: Recombinant mouse OB protein: Evidence for a peripheral signal linking adiposity and central neural networks. Science 1995;269:546–549.
14.
Rasmussen DD, Liu JH, Swartz WH, Tueros VS, Yen SS: Human fetal hypothalamic GnRH neurosecretion: Dopaminergic regulation in vitro. Clin Endocrinol (Oxf) 1986;25:127–132.
15.
Rasmussen DD, Liu JH, Wolf PL, Yen SS: Neurosecretion of human hypothalamic immunoreactive beta-endorphin: In vitro regulation by dopamine. Neuroendocrinology 1987;45:197–200.
16.
Schicatano EJ, Basso MA, Evinger C: Animal model explains the origins of the cranial dystonia benign essential blepharospasm. J Neurophysiol 1997;77:2842–2846.
© 2002 S. Karger AG, Basel
2002
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.